Clinical Trial
Published on 14 Dec 2023
Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial
in Neuro-Oncology and Neurosurgical Oncology
- 1,704 views
- 2 citations